Strain Information | |
---|---|
Image | |
BRC No. | RBRC11090 |
Type | CRISPR/Cas9 (Transgene) |
Species | Mus musculus |
Strain name | C57BL6/J-Actb<em1(tetO-PA-cre)ttaka> |
Former Common name | TRE-PA-Cre |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | Developed and deposited by Takeshi Takarada, in 2020. Mice were generated using C57BL/6J with the CRISPR/Cas9. C57BL/6J genetic background. |
Strain description | Knockin mice in which TRE-PA (photoactivatable)-Cre is placed downstream of exon 6 of the Actb. |
Colony maintenance | |
References | Establishment of a tTA-dependent photoactivatable Cre recombinase knock-in mouse model for optogenetic genome engineering. Takao T, Hiraoka Y, Kawabe K, Yamada D, Ming L, Tanaka K, Sato M, Takarada T Biochem. Biophys. Res. Commun., 526(1):213-217 (2020). 32204914 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
SV40 polyA | 5 | more 1 Diseases | |||||
Actb | actin, beta | 5 | Actb | endonuclease-mediated mutation 1, Takeshi Takarada | more 1 Diseases | ||
P2A | porcine teschovirus-1 2A peptide | 5 | P2A | E. coli tetO (tetracycline operator), CMV promoter | more 1 Diseases | ||
cre | Phage P1 Cre recombinase | 5 | cre | more 1 Diseases | |||
nls | SV40 large T antigen nuclear localization signal (NLS) | 5 | nls | more 1 Diseases |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Cytomegalovirus minimum CMV promoter, E. coli TRE(Tetracycline response element;tetO operator sequence), phage P1 Cre recombinase, Neurospora crassa pMag/nMag, SV40 nls, P2A (porcine teschovirus-1 2A peptide), SV40 polyA, mouse Actb genomic DNA |
Research application | Cre/loxP system Tet system |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Biochem. Biophys. Res. Commun., 526(1):213-217 (2020).When the RECIPIENT obtain approval from the DEPOSITOR. the RECIPIENT must agreement on terms transfer and conditions of use of it with DEPOSITOR. |
Depositor | Takeshi Takarada (Okayama University) |
Strain Status | Frozen sperm |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- Mouse of the Month Mar 2022 |
BRC mice in Publications |
---|
No Data |